1
|
Sano T, Kamiya J, Nagino M, et al:
Macroscopic classification and preoperative diagnosis of
intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat
Surg. 6:101–107. 1999. View Article : Google Scholar : PubMed/NCBI
|
2
|
Yamasaki S: Intrahepatic
cholangiocarcinoma: macroscopic type and stage classification. J
Hepatobiliary Pancreat Surg. 10:288–291. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu
J and Ikeda H: Pathological classification of intrahepatic
cholangiocarcinoma based on a new concept. World J Hepatol.
2:419–427. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Nakanuma Y, Sasaki M, Ikeda H, et al:
Pathology of peripheral intrahepatic cholangiocarcinoma with
reference to tumorigenesis. Hepatol Res. 38:325–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Roskams T: Liver stem cells and their
implication in hepato-cellular and cholangiocarcinoma. Oncogene.
25:3818–3822. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kuver R, Savard CE, Lee SK, Haigh WG and
Lee SP: Murine gallbladder epithelial cells can differentiate into
hepatocyte-like cells in vitro. Am J Physiol Gastrointest Liver
Physiol. 293:G944–G955. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Maeda T, Kajiyama K, Adachi E, Takenaka K,
Sugimachi K and Tsuneyoshi M: The expression of cytokeratins 7, 19,
and 20 in primary and metastatic carcinomas of the liver. Mod
Pathol. 9:901–909. 1996.PubMed/NCBI
|
8
|
Chu PG, Ishizawa S, Wu E and Weiss LM:
Hepatocyte antigen as a marker of hepatocellular carcinoma: an
immunohistochemical comparison to carcinoembryonic antigen, CD 10,
and alpha-fetoprotein. Am J Surg Pathol. 26:978–988. 2002.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Fan Z, van de Rijn M, Montgomery K and
Rouse RV: Hep Par 1 antibody stain for the differential diagnosis
of hepatocellular carcinoma: 676 tumors tested using tissue
microarrays and conventional tissue sections. Mod Pathol.
16:137–144. 2003. View Article : Google Scholar
|
10
|
Mosnier J-F, Kandel C, Cazals-Hatem D, et
al: N-cadherin serves as diagnostic biomarker in intrahepatic and
perihilar cholangiocarcinomas. Mod Pathol. 22:182–190. 2009.
View Article : Google Scholar : PubMed/NCBI
|
11
|
D'Errico A, Baccarini P, Fiorentino M, et
al: Histogenesis of primary liver carcinomas: strengths and
weaknesses of cytokeratin profile and albumin mRNA detection. Hum
Pathol. 27:599–604. 1996. View Article : Google Scholar : PubMed/NCBI
|
12
|
Yan BC, Gong C, Song J, et al: Arginase-1:
a new immunohistochemical marker of hepatocytes and hepatocellular
neoplasms. Am J Surg Pathol. 34:1147–1154. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Nakajima T, Kondo Y, Miyazaki M and Okui
K: A histopathologic study of 102 cases of intrahepatic
cholangiocarcinoma: histologic classification and modes of
spreading. Hum Pathol. 19:1228–1234. 1988. View Article : Google Scholar
|
14
|
Roskams TA, Theise ND, Balabaud C, et al:
Nomenclature of the finer branches of the biliary tree: canals,
ductules, and ductular reactions in human livers. Hepatology.
39:1739–1745. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhou H, Rogler LE, Teperman L, Morgan G
and Rogler CE: Identification of hepatocytic and bile ductular cell
lineages and candidate stem cells in bipolar ductular reactions in
cirrhotic human liver. Hepatology. 45:716–724. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Sasaki A, Kawano K, Aramaki M, Nakashima
K, Yoshida T and Kitano S: Immunohistochemical expression of
cytokeratins in intrahepatic cholangiocarcinoma and metastatic
adenocarcinoma of the liver. J Surg Oncol. 70:103–108. 1999.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Aishima S, Asayama Y, Taguchi K, et al:
The utility of keratin 903 as a new prognostic marker in
mass-forming-type intra-hepatic cholangiocarcinoma. Mod Pathol.
15:1181–1190. 2002. View Article : Google Scholar : PubMed/NCBI
|
18
|
Guedj N, Zhan Q, Perigny M, et al:
Comparative protein expression profiles of hilar and peripheral
hepatic cholangiocarcinomas. J Hepatol. 51:93–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Lau SK, Prakash S, Geller SA and Alsabeh
R: Comparative immunohistochemical profile of hepatocellular
carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum
Pathol. 33:1175–1181. 2002. View Article : Google Scholar
|
20
|
Kakar S, Muir T, Murphy LM, Lloyd RV and
Burgart LJ: Immunoreactivity of Hep Par 1 in hepatic and
extrahepatic tumors and its correlation with albumin in situ
hybridization in hepatocellular carcinoma. Am J Clin Pathol.
119:361–366. 2003. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tsuji M, Kashihara T, Terada N and Mori H:
An immunohistochemical study of hepatic atypical adenomatous
hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with
α-fetoprotein, carcinoembrionic antigen, CA19-9, epithelial
membrane antigen, and cytokeratins 18 and 19. Pathol Int.
49:310–317. 1999.PubMed/NCBI
|